Sarah Parish
BSc, MSc, DPhil
Professor of Medical Statistics and Epidemiology
- MRC Programme Leader
Sarah Parish studied Mathematics at Bristol and Oxford Universities and joined the unit which became CTSU (and is now part of NDPH) in 1978. She has played a major role as a statistician in the establishment, conduct and interpretation of CTSU’s series of ground-breaking large-scale randomised trials in the treatment and prevention of cardiovascular disease. She has also been active in developing large-scale blood-based observational studies with extensive biomarker panels and genotyping. As the Director of Statistics in Vascular Trials and Genetic Epidemiology, she now leads statistical teams engaged in a spectrum of complimentary research. Her particular interests include: identifying genetic risk factors for the side-effects of common cardiovascular treatments; investigating causality in relation to factors such as adiposity and dementia that are responsible for major burdens of disease, using the large UK and China Kadoorie biobanks.
Recent publications
-
Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom.
Journal article
Hopewell JC. et al, (2020), Eur Heart J, 41, 3336 - 3342
-
Investigating modifications to participant information materials to improve recruitment into a large randomized trial.
Journal article
HPS2-THRIVE Collaborative Group None. et al, (2019), Trials, 20
-
Effects of omega−3 fatty acid supplements on arrhythmias
Journal article
PARISH S. et al, (2019), Circulation
-
Impact of history of vascular disease on lipoprotein(a) associations with cardiovascular outcomes: a Mendelian randomisation study in 283,658 UK Biobank participants
Conference paper
Stiby A. et al, (2019), EUROPEAN HEART JOURNAL, 40, 684 - 684
-
Risk of major gastrointestinal bleed in relation to vascular disease risk in 0.5M UK Biobank participants
Conference paper
Hammami I. et al, (2019), EUROPEAN HEART JOURNAL, 40, 265 - 265